ORIENTAL RISE HOLDINGS LTD (ORIS)

Common Stock

1.7  -0.15 (-8.11%)

After market: 1.69 -0.01 (-0.59%)

Fundamental Rating

5

Taking everything into account, ORIS scores 5 out of 10 in our fundamental rating. ORIS was compared to 89 industry peers in the Food Products industry. While ORIS has a great health rating, its profitability is only average at the moment. ORIS has a valuation in line with the averages, but it does not seem to be growing.



6

1. Profitability

1.1 Basic Checks

ORIS had positive earnings in the past year.
ORIS had a positive operating cash flow in the past year.

1.2 Ratios

Looking at the Return On Assets, with a value of 16.98%, ORIS belongs to the top of the industry, outperforming 96.39% of the companies in the same industry.
ORIS has a better Return On Equity (18.24%) than 84.34% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.67%, ORIS belongs to the top of the industry, outperforming 91.57% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ORIS is significantly above the industry average of 8.88%.
Industry RankSector Rank
ROA 16.98%
ROE 18.24%
ROIC 13.67%
ROA(3y)19.13%
ROA(5y)N/A
ROE(3y)20.47%
ROE(5y)N/A
ROIC(3y)15.4%
ROIC(5y)N/A

1.3 Margins

ORIS has a Profit Margin of 47.68%. This is amongst the best in the industry. ORIS outperforms 98.80% of its industry peers.
ORIS has a Operating Margin of 47.28%. This is amongst the best in the industry. ORIS outperforms 100.00% of its industry peers.
Looking at the Gross Margin, with a value of 53.00%, ORIS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
OM 47.28%
PM (TTM) 47.68%
GM 53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ORIS is creating value.
ORIS has about the same amout of shares outstanding than it did 1 year ago.
ORIS has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 7.99 indicates that ORIS is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 7.99, ORIS belongs to the best of the industry, outperforming 92.77% of the companies in the same industry.
ORIS has a debt to FCF ratio of 0.25. This is a very positive value and a sign of high solvency as it would only need 0.25 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.25, ORIS belongs to the top of the industry, outperforming 91.57% of the companies in the same industry.
ORIS has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
ORIS has a better Debt to Equity ratio (0.04) than 78.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.25
Altman-Z 7.99
ROIC/WACC1.87
WACC7.31%

2.3 Liquidity

A Current Ratio of 8.86 indicates that ORIS has no problem at all paying its short term obligations.
The Current ratio of ORIS (8.86) is better than 98.80% of its industry peers.
ORIS has a Quick Ratio of 8.41. This indicates that ORIS is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ORIS (8.41) is better than 98.80% of its industry peers.
Industry RankSector Rank
Current Ratio 8.86
Quick Ratio 8.41

0

3. Growth

3.1 Past

ORIS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.97%.
Looking at the last year, ORIS shows a decrease in Revenue. The Revenue has decreased by -0.76% in the last year.
EPS 1Y (TTM)-2.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.97%
Revenue 1Y (TTM)-0.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 3.21 indicates a rather cheap valuation of ORIS.
Based on the Price/Earnings ratio, ORIS is valued cheaply inside the industry as 96.39% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ORIS to the average of the S&P500 Index (27.25), we can say ORIS is valued rather cheaply.
Industry RankSector Rank
PE 3.21
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ORIS indicates a rather cheap valuation: ORIS is cheaper than 100.00% of the companies listed in the same industry.
ORIS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ORIS is cheaper than 92.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.4
EV/EBITDA 0.28

4.3 Compensation for Growth

The decent profitability rating of ORIS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ORIS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ORIENTAL RISE HOLDINGS LTD

NASDAQ:ORIS (1/7/2025, 8:03:59 PM)

After market: 1.69 -0.01 (-0.59%)

1.7

-0.15 (-8.11%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap36.98M
AnalystsN/A
Price TargetN/A
Short Float %11.25%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.21
Fwd PE N/A
P/S 1.53
P/FCF 3.4
P/OCF 2.93
P/B 0.59
P/tB 0.59
EV/EBITDA 0.28
EPS(TTM)0.53
EY31.18%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.5
FCFY29.41%
OCF(TTM)0.58
OCFY34.17%
SpS1.11
BVpS2.9
TBVpS2.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.98%
ROE 18.24%
ROCE 18.04%
ROIC 13.67%
ROICexc 30.84%
ROICexgc 30.84%
OM 47.28%
PM (TTM) 47.68%
GM 53%
FCFM 45.08%
ROA(3y)19.13%
ROA(5y)N/A
ROE(3y)20.47%
ROE(5y)N/A
ROIC(3y)15.4%
ROIC(5y)N/A
ROICexc(3y)28.03%
ROICexc(5y)N/A
ROICexgc(3y)28.03%
ROICexgc(5y)N/A
ROCE(3y)20.46%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.25
Debt/EBITDA 0.21
Cap/Depr 158.69%
Cap/Sales 7.31%
Interest Coverage 83.87
Cash Conversion 100.95%
Profit Quality 94.54%
Current Ratio 8.86
Quick Ratio 8.41
Altman-Z 7.99
F-Score6
WACC7.31%
ROIC/WACC1.87
Cap/Depr(3y)391.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)14.85%
Cap/Sales(5y)N/A
Profit Quality(3y)71.78%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.94%
OCF growth 3YN/A
OCF growth 5YN/A